|
|
During our Board Meeting a few weeks ago, our members had the pleasure of meeting in person after a while and welcomed the new members of the EURO-NMD. Our coordinator shared a few words on this subject during the event: "It was fantastic to see you all again at the EURO-NMD Board meeting in Brussels last Wednesday, July 6th. It was impressive to see what a big network we have become: 84 members in 25 countries! The EURO-NMD coordination team and I would like to thank you for being present, despite the odds of the sanitary situation. Big thanks for their efforts to those intending to join us but had to abandon for health and strike issues. Thank you for being present and committed to our EURO-NMD network." Teresinha Evangelista - EURO-NMD Coordinator
|
|
|
|
|
Following the ERN's motto: "knowledge travels, not the patient" we are pleased to announce that the EU is funding an Exchange Training Programme. Through this programme your travel costs will be financed, and you will receive a daily allowance of 200€ per working day for your accommodation, travel insurance and subsistence costs. This Exchange Programme foresees 5 training days in another facility of the network which can be extended up to six weeks. The target population for this programme are healthcare professionals from ERN Euro-NMD, and in specific cases, patient representatives. Here is how it works:
|
|
|
|
|
| |
The Neuromuscular Translational School, organized by EURO-NMD and TREAT-NMD, focuses on therapy development from bench to bedside with a focus on neuromuscular disorders. The Translational School contains lectures about the current state of the art of acquired and genetic neuromuscular diseases, the different steps of drug development and the tools needed for this (outcome measures, biomarkers etc.). It also stresses how patients should play a role in these steps and teaches how to communicate research to patients and the general public during interactive workshop sessions. The Translational School will take place in autumn this year from November 21-25 in Leiden University Medical Center, the Netherlands.
|
|
|
|
|
|
We have produced 8 videos explaining the use of the CPMS to facilitate understanding of the CPMS platform. You will find brief and easy-to-follow videos of around 2 minutes duration each. No more sitting through endless videos about what you already know, patiently waiting to learn something new. Choose your subject and watch just what you need to know.
|
|
|
|
|
ERN EURO-NMD is looking for a Senior Project Manager M/F. The purpose of the Senior Project Manager position is to accomplish the objectives defined in the EU grants of the EURO-NMD. This involves ensuring proper functioning, development and implementation of the network activities in cooperation with the ERN members. Come and work with a great TEAM in the heart of a unique European capital!
|
|
|
|
|
ERN EURO-NMD is participating in a transversal cross-ERN Study Group on Pregnancy and Family Planning in Rare Diseases. The survey we present aims at collecting European-wide evidence on managing pregnancy and family planning for RD families.It is a survey for patients on "Unmet needs of rare and complex diseases related to pregnancy and family planning for patients and caregivers".
If you were so kind as to share this survey with European-based patients and patient organizations, that would be very helpful. 📢 The deadline has been extended !
|
|
|
|
|
In partnership with ERN-RND, ERN Epicare and EAN, we are pleased to announce that we will be participating in the World Mitochondrial Awareness Week 2022 with a series of educational webinars delivered by experts. Registrations are open:
Thurs September 1st 16:00-17:00 Paris time Mitochondrial Epilepsy
Wed September 21st 16:00-17:00 Paris time Mitochondrial Movement Disorders
Thurs September 22st 16:00-17:00 Paris time Mitochondrial Genetics
Thu September 29th 16:00-17:00 Paris time Mitochondrial Optical Neuropathies
|
|
|
|
|
If you missed a webinar, don't panic! We record all our webinars and they are available on our website.
|
|
|
|
Tuesday 13 September 2022, 3-4pm CEST
Vanishing white matter by Marjo van der Knaap The speaker is Full Professor of Pediatric Neurology and head of the research group 'white matter diseases in children' at the Amsterdam University Medical Center in the Netherlands.
Tuesday 20 September 2022, 3-4pm CEST
Tau-targeting Therapies: Where are we heading to? by Günter Höglinger The speaker is Full Professor and Director of the Department of Neurology at the Hannover Medical School, Germany. He is also a research group leader at DZNE (German Center for Neurodegenerative Diseases) in Munich. He conducts research in the field of neurodegenerative Parkinson syndromes with the goal of understanding the molecular mechanisms leading to the development and progression of neuronal dysfunction and death and of using these findings for diagnostic and therapeutic purposes. His particular focus is the interface between preclinical and clinical research.
Tuesday 27 September 2022, 3-4pm CEST
Clinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson's disease by Daniel Weiß The speaker is Professor at the University of Tübingen and leads the working group on deep brain stimulation at the Hertie Institute for Clinical Brain Research in Tübingen, Germany.
|
|
|
|
|
The "All ePAG meeting" will be held online from 14-17 November 2022. This year's theme is "How to get better at listening to your community to represent their needs and perspectives". It was inspired by a guide co-developed by EURORDIS and the ePAG community: Speak Up. Listen Up. Follow-Up guide: A brief guide for rare disease patient organisations on how to listen to the community. Throughout the week, we will reflect on why listening to your community matters, how to best capture my community's voice and where to start and celebrate some excellent examples from different perspectives. To know more, check the 👉 meeting's agenda.
|
|
|
|
|
The World Muscle Society is delighted to invite you to attend the 27th International Hybrid Annual Congress of the World Muscle Society that will take place 11th – 15th October 2022, in Halifax, Nova Scotia, Canada. The congress venue is the Halifax Convention Centre at 1650 Argyle Street, in the heart of this Atlantic seaport. For delegates who wish to attend virtually, the presentations and e-posters are available via the Congress platform and app.
The main thematic topics that will be addressed in the plenary sessions are : 1. New Developments in Congenital Muscle Disease 2. Neuropathies and Non-5q Motor Neuron Disease 3. The Development of Therapeutic Approaches
|
|
|
|
|
|
|
The World Duchenne Awareness Day, which will take place on September 7th, is the official campaign to raise awareness for people living with Duchenne & Becker muscular dystrophy. Each year, an educational theme is chosen; this year’s theme is Women and Duchenne. Through the creation of specific educational materials, the event will highlight all the interconnected aspects of Duchenne and the female world.
|
|
|
|
|
|
AFM-Telethon is pleased to announce that it will hold its 7th International Myology Congress in person, from September 12th to 15th, 2022 at the Nice Acropolis Congress Center, followed by mitoNice from September 15th to 17th, an international congress dedicated to Mitochondrial Medicine. A joint session in the afternoon of September 15th will ensure a smooth transition between the two congresses.
ERN EURO-NMD will have a booth. We will tell you very soon where you can find us. We look forward to seeing you there !
|
|
|
|
|
|
|
The 6th edition of Duchenne Patient Academy will take place on December 1 – 3 2022. This edition's theme is ‘Changing Perspectives’. The Academy provides online training for Duchenne and Becker muscular dystrophy (DMD/BMD) patient advocates. Over the course of 3 days, Duchenne Patient Academy 2022 attendees will listen to speakers and attend panel discussions moderated by experts in their respective fields. As with last year, attendees have the opportunity to become involved in the dialogue and share their experiences.
|
|
|
|
|
|
IRDiRC has four Scientific Committees, one each for Diagnostics, Therapies, Interdisciplinary, and Regulatory aspects of rare diseases research. The Diagnostic Scientific Committee (DSC) identifies current and future bottlenecks to rare disease gene discovery, addresses challenges and roadblocks in rare disease diagnosis, and collaborates with international partners to develop tools and resources to facilitate genomic data discovery, analyses and sharing. IRDiRC is looking for clinicians and experts in genetics, genomics, bioinformatics, molecular diagnostics, and biochemistry who can commit to quarterly teleconferences, a yearly face-to-face meeting, and regular committee activities, including email correspondence. Interested candidates are invited to send their resume, biosketch and letter of motivation to scisec-irdirc@ejprarediseases.org before the 14th of August 2022. More information about the The Diagnostic Scientific Committee (DSC) : https://irdirc.org/dsc/
|
|
|
|
|
The Networking Support Scheme (NSS) of the European Joint Programme on Rare Diseases is funding quarterly networking initiatives in the field of rare diseases and rare cancers, bringing together health care professionals, researchers, patient advocacy groups, Early Career Scientists and other relevant stakeholders.
You can submit your application from July 1, 2022 for events between February 15, 2023 and September 1, 2023.
The last collection dates for the Networking Support Scheme in EJP RD will be September 1, 2022 and December 1, 2022.
|
|
|
|